Literature DB >> 1573386

Human T-cell lymphotropic virus type 1 infection and tropical spastic paraparesis in Belgian expatriates.

P Goubau1, H Carton, P Cornet, G Vercauteren, A Van Gompel, H De Vooght, P Piot, J Desmyter.   

Abstract

A case of HTLV-1 associated tropical spastic paraparesis is described in a Belgian nun who had been working as a midwife in Central Africa. Occupational exposure was the only risk factor identified. Among 2,482 Belgian expatriates in tropical countries, 92% of whom had resided in sub-Saharan Africa for an average of 15.5 years, only one Belgian-born man was found seropositive for HTLV-1. He was married to an African woman and living in Central Africa for 23 years. The risk of HTLV-1 infection is low in Belgian expatriates and on its own does not support generalised anti-HTLV screening in autochthonous Belgian blood donors.

Entities:  

Mesh:

Year:  1992        PMID: 1573386     DOI: 10.1002/jmv.1890360103

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

1.  Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.

Authors:  D Agranoff; K Varney; H Khayam-Bashi; E L Murphy
Journal:  West J Med       Date:  1996-06

2.  Human T-cell lymphotropic virus type 1 exposures following blood-borne virus incidents in central Australia, 2002-2012.

Authors:  S Hewagama; S Krishnaswamy; L King; J Davis; R Baird
Journal:  Clin Infect Dis       Date:  2014-04-11       Impact factor: 9.079

Review 3.  HTLV-1 Transmission and HIV Pre-exposure Prophylaxis: A Scoping Review.

Authors:  Daniel Bradshaw; Graham Philip Taylor
Journal:  Front Med (Lausanne)       Date:  2022-04-29

4.  Work-Related Human T-lymphotropic Virus 1 and 2 (HTLV-1/2) Infection: A Systematic Review.

Authors:  Angela Stufano; Hamid Reza Jahantigh; Francesco Cagnazzo; Francesca Centrone; Daniela Loconsole; Maria Chironna; Piero Lovreglio
Journal:  Viruses       Date:  2021-09-02       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.